Single cell analysis reveals distinct immune landscapes in transplant and primary sarcomas that determine response or resistance to immunotherapy
2020 · Nature Communications · 108 citations
https://doi.org/10.1038/s41467-020-19917-0
C
Collin Kent
Duke University(US)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
448
Citations
10
h-index
10
i10-index
Collin Kent is an academic researcher from Duke University. The author has contributed to research in topics: Meningioma and schwannoma management & Glioma Diagnosis and Treatment & CAR-T cell therapy research. The author has an h-index of 10, co-authored 23 publications.
ORCID: 0000-0003-2628-6679Papers by this author
worksLong-Term Outcomes for Patients With Atypical or Malignant Meningiomas Treated With or Without Radiation Therapy: A 25-Year Retrospective Analysis of a Single-Institution Experience
2021 · Advances in Radiation Oncology · 19 citations
https://doi.org/10.1016/j.adro.2021.100878
Enhancing Radiotherapy Response via Intratumoral Injection of the TLR9 Agonist CpG to Stimulate CD8 T Cells in an Autochthonous Mouse Model of Sarcoma
2024 · International Journal of Radiation Oncology*Biology*Physics · 2 citations
https://doi.org/10.1016/j.ijrobp.2024.07.1081
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat